| Metric | Value ($ M) |
|---|---|
| Revenue | 0.35 |
| Total Income | 0.35 |
| Expenditure | 22.83 |
| PBT | — |
| Net Profit | 8.20 |
| OPM | — |
| NPM | 100.00% |
| EPS | 0.94 |
Seres Therapeutics Announces Q3 2025 Financial Results
04 May 2026 · 4 May, 8:06 am
Summary
Seres Therapeutics, Inc. announced its financial results for the quarter ended September 30, 2025, via a press release issued on November 5, 2025. The press release also included operational updates. An updated corporate presentation was posted on the company's website in the "Investors and News" section.
Key Highlights
- 1
Seres Therapeutics announced its financial results for the quarter ended September 30, 2025.
- 2
The announcement was made via a press release issued on November 5, 2025.
- 3
Operational updates were provided in the press release.
- 4
An updated corporate presentation was posted on the company's website.
Informational and educational content only. Not investment advice.